NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,992,672 | +12.0% | 863,859 | +10.9% | 0.15% | +12.2% |
| Q2 2023 | $78,587,051 | +2.7% | 778,784 | -6.3% | 0.13% | -0.8% |
| Q1 2023 | $76,490,294 | -11.8% | 831,416 | -13.0% | 0.13% | -13.7% |
| Q4 2022 | $86,708,284 | +18.1% | 955,779 | -1.1% | 0.15% | +8.5% |
| Q3 2022 | $73,440,000 | -10.8% | 966,195 | -0.8% | 0.14% | -6.6% |
| Q2 2022 | $82,356,000 | -14.3% | 974,284 | -11.0% | 0.15% | -0.7% |
| Q1 2022 | $96,054,000 | +7.8% | 1,094,633 | +7.5% | 0.15% | +11.8% |
| Q4 2021 | $89,080,000 | +5.2% | 1,018,400 | -1.6% | 0.14% | -2.2% |
| Q3 2021 | $84,664,000 | -7.2% | 1,035,261 | +3.5% | 0.14% | -6.7% |
| Q2 2021 | $91,225,000 | +10.2% | 999,838 | +3.2% | 0.15% | +3.5% |
| Q1 2021 | $82,807,000 | -2.0% | 968,735 | +8.3% | 0.14% | -10.6% |
| Q4 2020 | $84,490,000 | +15.7% | 894,736 | +6.5% | 0.16% | +1.3% |
| Q3 2020 | $73,043,000 | +0.4% | 839,971 | +0.8% | 0.16% | -2.5% |
| Q2 2020 | $72,777,000 | +9.5% | 833,252 | +3.4% | 0.16% | -6.9% |
| Q1 2020 | $66,462,000 | -6.9% | 806,092 | +6.9% | 0.18% | +20.7% |
| Q4 2019 | $71,390,000 | +458.9% | 753,928 | +412.9% | 0.14% | -33.8% |
| Q3 2019 | $12,774,000 | -7.2% | 146,993 | -2.5% | 0.22% | -8.0% |
| Q2 2019 | $13,770,000 | -9.2% | 150,809 | -4.4% | 0.24% | -12.2% |
| Q1 2019 | $15,160,000 | +4.3% | 157,685 | -6.9% | 0.27% | -9.1% |
| Q4 2018 | $14,534,000 | -3.6% | 169,385 | -3.2% | 0.30% | +10.0% |
| Q3 2018 | $15,075,000 | +12.6% | 174,969 | -1.3% | 0.27% | +6.3% |
| Q2 2018 | $13,391,000 | -19.8% | 177,265 | -14.2% | 0.26% | -20.1% |
| Q1 2018 | $16,701,000 | -17.1% | 206,565 | -13.9% | 0.32% | -15.2% |
| Q4 2017 | $20,136,000 | -24.7% | 239,826 | -23.0% | 0.38% | -27.6% |
| Q3 2017 | $26,751,000 | -0.1% | 311,593 | -2.9% | 0.52% | -2.3% |
| Q2 2017 | $26,789,000 | +10.4% | 320,950 | -1.7% | 0.53% | +8.8% |
| Q1 2017 | $24,258,000 | +10.4% | 326,612 | +8.3% | 0.49% | +8.7% |
| Q4 2016 | $21,972,000 | -5.1% | 301,661 | +2.8% | 0.45% | -5.7% |
| Q3 2016 | $23,160,000 | -3.4% | 293,304 | +0.9% | 0.48% | -5.6% |
| Q2 2016 | $23,974,000 | +17.8% | 290,549 | +3.4% | 0.50% | -4.2% |
| Q1 2016 | $20,350,000 | -11.0% | 280,926 | +5.6% | 0.53% | -11.3% |
| Q4 2015 | $22,878,000 | -10.6% | 265,905 | -4.5% | 0.59% | -10.8% |
| Q3 2015 | $25,587,000 | -9.9% | 278,371 | -3.6% | 0.66% | -13.3% |
| Q2 2015 | $28,404,000 | -5.4% | 288,825 | -5.1% | 0.77% | -11.0% |
| Q1 2015 | $30,020,000 | -4.9% | 304,437 | -10.7% | 0.86% | -7.0% |
| Q4 2014 | $31,583,000 | -3.0% | 340,848 | -1.4% | 0.93% | -5.8% |
| Q3 2014 | $32,553,000 | +0.4% | 345,829 | -3.4% | 0.98% | +1.3% |
| Q2 2014 | $32,409,000 | +2.8% | 357,997 | -3.5% | 0.97% | -2.2% |
| Q1 2014 | $31,526,000 | +5.0% | 370,802 | -0.8% | 0.99% | +2.6% |
| Q4 2013 | $30,035,000 | +7.2% | 373,675 | +2.3% | 0.97% | -2.5% |
| Q3 2013 | $28,025,000 | +11.2% | 365,334 | +2.5% | 0.99% | +5.8% |
| Q2 2013 | $25,201,000 | – | 356,410 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |